Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 025703/0686 | |
| Pages: | 7 |
| | Recorded: | 01/26/2011 | | |
| Attorney Dkt #: | 17716-CIP1 (BOT) |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12904983
|
Filing Dt:
|
10/14/2010
|
|
Publication #:
|
|
Pub Dt:
|
05/12/2011
| | | | |
|
Title:
|
Optimizing Expression of Active Botulinum Toxin Type E
|
|
|
Assignee
|
|
|
|
|
| 2525 DUPONT DRIVE, T2-7H |
| IRVINE, CALIFORNIA 92612 |
|
|
Correspondence name and address
|
| |
KENTON ABEL/ALLERGAN, INC.
|
| |
2525 DUPONT DRIVE, T2-7H
|
| |
IRVINE, CA 92612
|
Search Results as of:
05/23/2024 06:03 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
